Immunological recovery in tuberculosis/HIV co-infected patients on antiretroviral therapy: implication for tuberculosis preventive therapy.

Karo, Basel; Krause, Gerard; Castell, Stefanie; Kollan, Christian; Hamouda, Osamah; Haas, Walter

Name:

Karo et al.pdf

Size:

748.9Kb

Format:

PDF

Description:

Open Access publication

Download

Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item. When enough users have cast their vote on this item, the average rating will also be shown.

Star rating

Your vote was cast
Thank you for your feedback

Authors

Karo, Basel
Krause, Gerard

Castell, Stefanie
Kollan, Christian
Hamouda, Osamah
Haas, Walter

Issue Date

2017-07-25

Metadata

Show full item record

Abstract

Understanding the immune response to combination antiretroviral therapy (cART) is essential for a clear approach to tuberculosis (TB) preventive therapy. We investigated the immunological recovery in cART-treated HIV-infected patients developing TB compared to those who remained free of TB.

Citation

Immunological recovery in tuberculosis/HIV co-infected patients on antiretroviral therapy: implication for tuberculosis preventive therapy. 2017, 17 (1):517 BMC Infect. Dis.

Type

Article

Language

ISSN

1471-2334

Collections

publications of the research group of epidemiology (EPID)

The following license files are associated with this item:

Creative Commons

Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc-sa/4.0/